Press Release Apr 27 2026
Filed with NSE · · 3 pages · English
Sun Pharmaceutical Industries Limited on 6ix
In the deck
Earlier from Sun Pharmaceutical Industries
- Sun Pharma signs Definitive Agreement to Acquire Organon
- Press Release Mar 27 2026
- Press Release Mar 21 2026
- Press Release Mar 16 2026
- Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis
Later from Sun Pharmaceutical Industries
- Sun Pharma To Acquire Organon
- Sun Pharmaceutical Industries, Inc. (Sun Pharma) Initiates Voluntary U.S. Nationwide Recall of DOXOrubicin Hydrochloride Liposome...
- Press Release May 26 2026
- At the ASCO® 2026 Annual Meeting, Sun Pharma to Present Pivotal Long-Term Follow-up Data on UNLOXCYT™ (cosibelimab-ipdl)
- American Skin Association annual gala recognizes Sun Pharma with corporate leadership award
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries